SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2019-05-23 12:25
Tx date 2019-03-15
$AQS
Aequus Pharmaceuticals Inc.
Stevens, Anne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-2,925
-13,000 vol
$0.225 each
0
Filed 2017-12-12
Tx date 2017-12-07
$AQS
Aequus Pharmaceuticals Inc.
Stevens, Anne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options

+300,000 vol
1,724,337
Filed 2016-11-16
Tx date 2016-11-16
$AQS
Aequus Pharmaceuticals Inc.
Stevens, Anne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$405.00
+1,500 vol
$0.27 each
13,000
Filed 2016-05-30
Tx date 2016-05-06
$AQS
Aequus Pharmaceuticals Inc.
Stevens, Anne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-460.00
-1,000 vol
$0.46 each
17,000
Filed 2016-05-30
Tx date 2016-05-20
$AQS
Aequus Pharmaceuticals Inc.
Stevens, Anne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$-2,585
-5,500 vol
$0.47 each
11,500
Filed 2016-05-06
Tx date 2016-04-21
$AQS
Aequus Pharmaceuticals Inc.
Stevens, Anne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$65,800
+140,000 vol
$0.47 each
Filed 2016-05-06
Tx date 2016-05-06
$AQS
Aequus Pharmaceuticals Inc.
Stevens, Anne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
$65,800
+140,000 vol
$0.47 each
1,424,337
Filed 2015-11-12
Tx date 2015-11-12
$AQS
Aequus Pharmaceuticals Inc.
Stevens, Anne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,000
+4,000 vol
$0.50 each
18,000
Filed 2015-04-30
Tx date 2015-04-29
$AQS
Aequus Pharmaceuticals Inc.
Stevens, Anne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market
$2,400
+4,000 vol
$0.60 each
14,000